Table of Contents













Indicators 2c
 1) Misoprostol registered for PAC
2) Misoprostol for PAC in Ministry of Health guidelines
3) Number of public sector trainers trained (TOT) in misoprostol for PAC
4) Inclusion of misoprostol for PAC in medical/nursing school curricula
5) Misoprostol for PAC on Essential Medicines List (EML)
6)  Percentage of eligible public sector facilities  in WHP EPSE project areas offering PAC services with misoprostol 
7)  Percentage of eligible public sector facilities  in WHP EPSE project areas with any provider trained in PAC, including misoprostol for PAC
8)  Percentage of eligible public sector facilities  in WHP EPSE project areas with misoprostol in stock
9) Percentage of eligible public sector facilities  in WHP EPSE project areas offering medical abortion services
10)  Percentage of  eligible public sector facilities  in WHP EPSE project areas with any provider trained in use of medical abortion
11)  Percentage of  eligible public sector facilities  in WHP EPSE project areas with medical abortion in stock

                                                 


 

Indicator

2c-1

  
Misoprostol registered for PAC
 
Workplan:  Demonstrate misoprostol registered for PAC by Dec. 2018
Indicator Type
 Mandatory unless already registered.
At least one PAC/Misoprostol advocacy indicator is required.
Choose based on country context or add additional appropriate indicator for your country.
Where Reported
 Workplan
Numerator
 Binary indicator - yes or no
Denominator
 N/A
Purpose
 To measure misoprostol advocacy
Data Source
 Publicly available government records; verifiable private information
Data Collection Frequency
 At least once during project period
Notes:
 Only choose this indicator if misoprostol is not currently registered for PAC.




















 

Indicator

2c-2

  
Misoprostol for PAC in Ministry of Health guidelines
 
Workplan:  Demonstrate that misoprostol use for PAC is a part of MoH guidelines by Dec. 2018
Indicator Type
 Mandatory unless already in the guidelines.
At least one PAC/Misoprostol advocacy indicator is required.
Choose based on country context or add additional appropriate indicator for your country.
Where Reported
 Workplan
Numerator
 Binary indicator - yes or no
Denominator
 N/A
Purpose
 To measure misoprostol advocacy
Data Source
 Publicly available government records; verifiable private information
Data Collection Frequency
 At least every 6 months
Notes:




















 

Indicator

2c-3

  
Number of public sector trainers trained (TOT) in misoprostol for PAC
 
Workplan: X public sector trainers trained (TOT) in misoprostol for PAC  by Dec. 2018
Indicator Type
 Mandatory for PAC countries
Where Reported
 Workplan Activity Level, Tracker
Numerator
 # of public sector trainers trained in misoprostol for PAC
Denominator
 N/A
Purpose
 To improve access to PAC
Data Source
 MIS
Data Collection Frequency
 As available; at least every 6 months
Notes:
 Tracker:
  • Record all public sector trainers who were trained (TOT) in misoprostol for PAC during that month. (Do not report the cumulative sum of public sector trainers trained in PAC over the life of the project.)
Workplan: 
  • Report number of public sector trainers trained on appropriate activity line in workplan under both “Total Project” and “Period Achievement”


























 

Indicator

2c-4

  
Inclusion of misoprostol for PAC in medical/nursing school curricula
 
Workplan:  Demonstrate inclusion of misoprostol for PAC practical training in medical/nursing school curricula by Dec. 2018
Indicator Type
 Mandatory unless already in curricula or other extenuating circumstances.
At least one PAC/Misoprostol advocacy indicator is required.
Choose based on country context or add additional appropriate indicator for your country.
Where Reported
 Workplan
Numerator
 Binary indicator - yes or no
Denominator
 N/A
Purpose
 To measure misoprostol advocacy
Data Source
 Publicly available government records; verifiable private information
Data Collection Frequency
 At least every 6 months
Notes:






















Indicator

2c-5

Misoprostol for PAC on Essential Medicines List (EML)
Workplan:  Demonstrate inclusion of misoprostol for PAC on national EML by Dec. 2018
Indicator Type
Mandatory unless already on the EML.
At least one PAC/Misoprostol advocacy indicator is required.
Choose based on country context or add additional appropriate indicator for your country.
Where Reported
Workplan
Numerator
Binary indicator - yes or no
Denominator
N/A
Purpose
To measure misoprostol advocacy
Data Source
Publicly available government records; verifiable private information
Data Collection Frequency
At least every 6 months
Notes:


 

Indicator

2c-6

  
Percentage of eligible public sector facilities in WHP EPSE project areas offering PAC services with misoprostol
 
Workplan:  Increase, from X to Y, the percentage of public sector facilities in WHP EPSE project areas offering PAC services with misoprostol
Indicator Type
 Mandatory for EPSE countries
Where Reported
 Workplan
Numerator
 # of eligible facilities in WHP EPSE project areas that, at the time of the survey, have a provider trained in PAC with misoprostol and have misoprostol in stock
Denominator
 total # of eligible facilities surveyed in WHP EPSE project areas
Purpose
 To measure  availability of PAC services with misoprostol
Data Source
 Public sector facility survey OR MIS data from public sector facilities
Data Collection Frequency
 Twice during project period
Notes:
 Method of Measurement:
  • Ensure that the sampling frame represents facilities at multiple levels
  • Ensure that the sampling frame represents facilities in EPSE areas
  • Refers to PAC services provided with misoprostol
  • Eligible facilities are those that are permitted to provide PAC services with misoprostol under country MOH guidelines
  • “Offering” PAC service with misoprostol is defined as having a provider trained in PAC with misoprostol and having misoprostol in stock at the time of the survey
  • The sampling frame should be limited to facilities legally authorized to provide PAC services
  • OR MIS data from public sector facilities
Workplan:
  • Record the number AND percentage of public sector facilities in WHP EPSE project areas offering PAC services with misoprostol.
 


































 

Indicator

2c-7

  
Percentage of eligible public sector facilities in WHP EPSE project areas with any provider trained in PAC, including misoprostol for PAC
 
Workplan:  Increase from X to Y the percentage of public sector facilities in WHP EPSE project areas with any provider trained in PAC by Dec. 2018
Indicator Type
 Mandatory for EPSE PAC countries
Where Reported
 Workplan
Numerator
 # of public sector facilities in WHP EPSE project areas with any provider trained in PAC
Denominator
 total # of eligible public sector facilities surveyed in WHP EPSE project areas
Purpose
 To measure misoprostol and PAC availability
Data Source
 Public sector facility survey OR MIS data from public sector facilities
Data Collection Frequency
 Twice during project period
Notes:
 Method of Measurement:
  • Ensure that the sampling frame represents facilities at multiple levels
  • Ensure that the sampling frame represents facilities in EPSE areas
  • PAC services must include training on misoprostol
  • Eligible facilities are those that are permitted to provide PAC services with misoprostol under country MOH guidelines
  • Facility must have a provider present who can perform PAC service
  • The sampling frame should be limited to facilities legally authorized to provide PAC services
  • OR MIS data from public sector facilities






























 

Indicator

2c-8

  
Percentage of eligible public sector facilities in WHP EPSE project areas with misoprostol in stock
 
Workplan:  Increase, from X to Y, the percentage of public sector facilities in WHP EPSE project areas with misoprostol in stock
Indicator Type
 Mandatory for EPSE PAC countries
Where Reported
 Workplan
Numerator
 # of eligible facilities in WHP EPSE project areas with misoprostol in stock at the time of the survey
Denominator
 total # of eligible facilities surveyed in WHP EPSE project areas
Purpose
 To measure misoprostol and PAC availability
Data Source
 Public sector facility survey OR MIS data from public sector facilities
Data Collection Frequency
 Twice during project period
Notes:
 Method of Measurement:
  • Ensure that the sampling frame represents facilities at multiple levels
  • Ensure that the sampling frame represents facilities in EPSE areas
  • Eligible facilities are those that are permitted to provide PAC services with misoprostol under country MOH guidelines
  • OR MIS data from public sector facilities
 

























 

Indicator

2c-9

  
Percentage of eligible public sector facilities in WHP EPSE project areas offering medical abortion services 
 
Workplan:  Increase, from X to Y, the percentage of public sector facilities in WHP EPSE project areas offering medical abortion services
Indicator Type
 Mandatory for EPSE MA countries
Where Reported
 Workplan
Numerator
 # of eligible facilities in WHP EPSE project areas that have, at the time of the survey, a trained provider for MA and MA in stock
Denominator
 total # of eligible facilities surveyed in WHP EPSE project areas
Purpose
 To measure availability of MA services
Data Source
 Public sector facility survey OR MIS data from public sector facilities
Data Collection Frequency
 Twice during project period
Notes:
 Method of Measurement:
  • Ensure that the sampling frame represents facilities in EPSE areas
  • Eligible facilities are those that are permitted to provide MA services under country MOH guidelines
  • Ensure that the sampling frame represents facilities at multiple levels
  • Medical abortion services provided with appropriate dosage of misoprostol and mifepristone
  • Facility must have MA in stock and a provider present who can perform the service
  • The sampling frame should be limited to facilities legally authorized to provide MA services
  • OR MIS data from public sector facilities
 





























 

Indicator

2c-10

  
Percentage of eligible public sector facilities in WHP EPSE project areas with any provider trained in use of medical abortion
 
Workplan:  Increase from X to Y the percentage  of public sector facilities in WHP EPSE project areas with any provider trained in use of medical abortion by Dec. 2018
Indicator Type
 Mandatory for EPSE MA countries
Where Reported
 Workplan
Numerator
 # of eligible public sector facilities in WHPEPSE project areas with any provider trained in use of MA
Denominator
 total # of eligible public sector facilities surveyed in WHP EPSE project areas
Purpose
 To measure availability of MA services
Data Source
 Public sector facility survey OR MIS data from public sector facilities
Data Collection Frequency
 Twice during project period
Notes:
 Method of Measurement:
  • Ensure that the sampling frame represents facilities in EPSE areas
  • Eligible facilities are those that are permitted to provide MA services under country MOH guidelines
  • Ensure that the sampling frame represents facilities at multiple levels
  • Facility must have a provider present who can perform MA service
  • The sampling frame should be limited to facilities legally authorized to provide MA services
  • OR MIS data from public sector facilities





























 

Indicator

2c-11

  
Percentage of eligible public sector facilities in WHP EPSE project areas with medical abortion in stock
 
Workplan:  Increase, from X to Y, the percentage of public sector facilities in WHP EPSE project areas with medical abortion in stock
Indicator Type
 Mandatory for EPSE MA countries
Where Reported
 Workplan
Numerator
 # of eligible public sector facilities in WHP EPSE project areas with medical abortion in stock at the time of the survey
Denominator
 total # of eligible public sector facilities surveyed in WHP EPSE project areas
Purpose
 To measure availability of medical abortion
Data Source
 Public sector facility survey OR MIS data from public sector facilities
Data Collection Frequency
 Twice during project period
Notes:
 Method of Measurement:
  • Ensure that the sampling frame represents facilities in EPSE areas
  • Eligible facilities are those that are permitted to provide MA services under country MOH guidelines
  • Ensure that the sampling frame represents facilities at multiple levels
  • Medical abortion in stock refers to availability of both misoprostol and mifepristone
  • The sampling frame should be limited to facilities legally authorized to provide MA services
  • OR MIS data from public sector facilities
 




























 

Indicator

2c-12

  
Advocacy Indicator for MA
 
Insert into workplan
Indicator Type
 MA countries must include at least one MA advocacy indicator as appropriate for their country
Where Reported
 Workplan
Numerator
 Binary indicator - yes or no
Denominator
 N/A
Purpose
 To measure MA advocacy
Data Source
Data Collection Frequency
 At least every 6 months
Notes:
 Guidance:
These could include:
  • Medical abortion registered for 2nd trimester abortions.
  • Medical abortion included in MOH guideline for 2nd trimester abortions.
  • Medical abortion included in medical/nursing school curricula for 2nd trimester abortions.
  • Midlevel providers permitted by law to perform medical abortions.